TME Alteration in HER2 Positive Breast Cancer
Evaluate for changes in the tumor microenvironment before/during neoadjuvant chemotherapy and after treatment in patients diagnosed with HER2-positive advanced breast cancer and receiving neoadjuvant cancer therapy and surgery for curative purposes.
Breast Cancer|HER2-positive Breast Cancer|Chemotherapy Effect
tumor microenvironment alteration, tumor microenvironment changes during neoadjuvant chemotherapy (NAC) for HER2-positive breast cancer., 6 months
Evaluate for changes in the tumor microenvironment before/during neoadjuvant chemotherapy and after treatment in patients diagnosed with HER2-positive advanced breast cancer and receiving neoadjuvant cancer therapy and surgery for curative purposes.